Obamacare's newest numbers are in: Who's doing well?
Some expected and surprising beneficiaries could emerge from Obamacare's stronger-than-expected enrollment figures.
DaVita's focus on outcomes-based medicine could be the right recipe for the future
The official end date for enrollment in Obamacare this year has passed. How do things look now that the dust is settling?
With the Obamacare enrollment deadline less than 48 hours away, here are the three most pressing questions that should be on the minds of investors.
Walgreen Company has underperformed other drugstore companies in recent years. Is it finally ready to bounce back?
Do short-sellers have these three stocks pegged? You be the judge!
More news out of Washington with eight days left in open enrollment.
Will it be toil and trouble for insurers if Obamacare premiums double in some areas as predicted by industry officials?
Bad news for insurers in a new CMS draft letter. What's next?